border=0
border=0
Enter any ticker symbol here to see the live quote & chart tools in action
Ticker:   
border=0 border=0 Benefits: /
  • Your filings are automatically published to your site as they are filed.
  • Investors don't have to leave your site to see filings.


  • Product Description
  • Once a report has been filed with the SEC it will be available on the website.



  • SEC Filings Section 16 Filings Only
     
    NOVADEL PHARMA INC filed this S-1/A on 11/05/2010.
    « Prev Page Outline Printer Friendly Entire FilingNext Page »

    NOVADEL PHARMA INC.
    BALANCE SHEETS AS OF DECEMBER 31, 2009 AND 2008

     

     

     

     

     

     

     

     

     

     

    December
    31,
    2009

     

    December
    31,
    2008

     

     

     


     


     

     

     

     

     

     

     

     

     

    ASSETS

     

     

     

     

     

     

     

    Current Assets:

     

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    2,663,000

     

    $

    4,328,000

     

    Assets held for sale

     

     

     

     

    299,000

     

    Deferred financing costs, net of accumulated amortization of $238,000 and $213,000, respectively

     

     

     

     

    25,000

     

    Prepaid expenses and other current assets

     

     

    1,430,000

     

     

    958,000

     

     

     



     



     

     

     

     

     

     

     

     

     

    Total Current Assets

     

     

    4,093,000

     

     

    5,610,000

     

    Property and equipment, net

     

     

    324,000

     

     

    1,447,000

     

    Other assets

     

     

    36,000

     

     

    259,000

     

     

     



     



     

     

     

     

     

     

     

     

     

    TOTAL ASSETS

     

    $

    4,453,000

     

    $

    7,316,000

     

     

     



     



     

     

     

     

     

     

     

     

     

    LIABILITIES AND STOCKHOLDERS’ DEFICIENCY

     

     

     

     

     

     

     

    Current Liabilities:

     

     

     

     

     

     

     

    Secured convertible notes payable, net of unamortized discount of zero and $403,000, respectively

     

    $

     

    $

    3,597,000

     

    Accounts payable

     

     

    195,000

     

     

    654,000

     

    Accrued expenses and other current liabilities

     

     

    117,000

     

     

    924,000

     

    Current portion of deferred revenue

     

     

    4,266,000

     

     

    266,000

     

    Current portion of capital lease obligations

     

     

    10,000

     

     

    122,000

     

     

     



     



     

    Total Current Liabilities

     

     

    4,588,000

     

     

    5,563,000

     

     

     

     

     

     

     

     

     

    Non-current portion of deferred revenue

     

     

    4,202,000

     

     

    4,468,000

     

    Non-current portion of capital lease obligations

     

     

    4,000

     

     

    26,000

     

     

     



     



     

     

     

     

     

     

     

     

     

    Total Liabilities

     

     

    8,794,000

     

     

    10,057,000

     

     

     



     



     

     

     

     

     

     

     

     

     

    COMMITMENTS AND CONTINGENCIES

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    STOCKHOLDERS’ DEFICIENCY

     

     

     

     

     

     

     

    Preferred stock, $.001 par value:

     

     

     

     

     

     

     

    Authorized 1,000,000 shares, none issued

     

     

     

     

     

    Common stock, $.001 par value:

     

     

     

     

     

     

     

    Authorized 200,000,000 shares, Issued 88,343,457 and 60,692,260 at December 31, 2009 and 2008, respectively

     

     

    89,000

     

     

    60,000

     

    Additional paid-in capital

     

     

    78,342,000

     

     

    72,034,000

     

    Accumulated deficit

     

     

    (82,766,000

    )

     

    (74,829,000

    )

    Less: Treasury stock, at cost, 3,012 shares

     

     

    (6,000

    )

     

    (6,000

    )

     

     



     



     

     

     

     

     

     

     

     

     

    Total Stockholders’ Deficiency

     

     

    (4,341,000

    )

     

    (2,741,000

    )

     

     



     



     

     

     

     

     

     

     

     

     

    TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY

     

    $

    4,453,000

     

    $

    7,316,000

     

     

     



     



     

    See accompanying notes to financial statements.

    F-3






    border=0
    Quote & Chart Package
    Basic Stock Chart
    Basic Stock Quote
    Embedded Quote / Chart
    Embedded Full Quote / Chart
    Interactive Chart
    Intraday Chart
    Pop Up Quote
    Scrolling Ticker

    You are viewing our Quote and Chart Demo using ticker symbol NVDL
    border=0

    T 800.650.1211     F 888.329.6696     E info@stockgroup.com   © 2004 Stockgroup Media Inc.    Disclaimer